What is a normal progesterone level in early pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Progesterone Levels in Early Pregnancy

In normal early pregnancy, serum progesterone levels range from approximately 57.5 nmol/L (18.3 ng/mL) at 5 weeks to 80.8 nmol/L (25.7 ng/mL) at 13 weeks gestation, with a linear increase throughout the first trimester. 1

Gestational Age-Specific Reference Ranges

Normal pregnancy progesterone distribution:

  • 5 weeks gestation: Median 57.5 nmol/L (18.3 ng/mL) 1
  • 13 weeks gestation: Median 80.8 nmol/L (25.7 ng/mL) 1
  • Linear increase pattern: Progesterone demonstrates a consistent upward trend throughout weeks 5-13 of gestation 1

The 10th to 90th percentile range widens as pregnancy advances, reflecting normal physiologic variation 1.

Clinical Thresholds for Viability Assessment

When evaluating symptomatic patients with bleeding or pain:

  • Progesterone <6.3 ng/mL (<20 nmol/L): Indicates non-viable pregnancy with 99.2% specificity and 73.1% sensitivity, yielding a positive predictive value of 91-99% depending on prevalence 2, 3

  • Progesterone 20-25 ng/mL (63.6-79.5 nmol/L): Indicates viable pregnancy with 75% specificity and 91.3% sensitivity, yielding a negative predictive value of 89-99% for non-viability 2

  • Progesterone 10 ng/mL (31.8 nmol/L): When used as a threshold in symptomatic women, predicts non-viable pregnancy with 96.3% specificity and 66.5% sensitivity 3

Critical caveat: A single progesterone level <5 ng/mL is suggestive but not absolutely diagnostic of non-viable pregnancy, as rare cases of viable pregnancies have been documented with levels as low as 1.2 ng/mL 4. Routine uterine curettage based solely on this threshold may interrupt desired viable pregnancies 4.

Comparison: Normal vs. Threatened Miscarriage

Threatened miscarriage progesterone patterns:

  • Median levels are uniformly lower by approximately 10 nmol/L at every gestational week compared to normal pregnancies 1
  • At 5 weeks: Median 41.7 nmol/L (13.3 ng/mL) in threatened miscarriage vs. 57.5 nmol/L in normal pregnancy 1
  • At 13 weeks: Median 78.1 nmol/L (24.8 ng/mL) in threatened miscarriage vs. 80.8 nmol/L in normal pregnancy 1

Pregnancies ending in miscarriage: Show marginal, non-significant increase from 19.0 to 30.3 nmol/L (6.0 to 9.6 ng/mL) between 5-13 weeks, contrasting sharply with the robust linear increase seen in viable pregnancies 1.

Physiologic Context

Corpus luteum function: Progesterone is produced by the corpus luteum until completion of the luteal-placental shift at approximately 6-10 weeks following last menstruation 4. During early gestation (first 10 weeks), serum progesterone levels below 15 ng/mL (47.7 nmol/L) are considered diagnostic of corpus luteum dysfunction 5.

Clinical Application Algorithm

For asymptomatic women with confirmed intrauterine pregnancy:

  • Routine progesterone testing is not indicated 6
  • Progesterone levels naturally increase linearly from 5-13 weeks 1

For symptomatic women (bleeding/pain) with inconclusive ultrasound:

  • Progesterone <6.3 ng/mL: 99.2% probability of non-viable pregnancy 2, 3
  • Progesterone 6.3-20 ng/mL: Indeterminate zone requiring serial hCG and repeat ultrasound 2, 3
  • Progesterone ≥20-25 ng/mL: >90% probability of viable pregnancy 2

Important limitation: Single progesterone measurements should not be used in isolation for clinical decision-making, particularly regarding pregnancy termination, as rare exceptions exist where very low levels (<5 ng/mL) can still be associated with viable pregnancies 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.